⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 21, 2024

Table S2 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma

Samera H. Hamad Rani S. Sellers Nathan Wamsley Paul Zolkind Travis P. Schrank Michael B. Major Bernard E. Weissman

View Full Paper

Ask AI

Bookmark

Share

Abstract

Table S2 shows TCGA data used to analyze mutations in TP53, CDKN2A, and NRF2 pathways.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hamad et al. (2024) studied this question.

synapsesocial.com/papers/68e78466b6db6435876f7b4a https://doi.org/10.1158/2767-9764.25259832

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S2 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
2Table S5 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
3Table S5 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
4Table S1 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024
5Table S1 from NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma2024